Reckitt Investors Lose Bid For Opioid Representative Claim
Investors' claims against Reckitt and Indivior over the misleading marketing of an opioid addiction drug can proceed only as multiparty proceedings, the Court of Appeal ruled Thursday, denting the prospects of...To view the full article, register now.
Already a subscriber? Click here to view full article